Working… Menu
Trial record 7 of 12 for:    Nafamostat

The Effect of Nafamostat Mesilate in Prolonging Filter Patency With Patients on Continuous Renal Replacement Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01761994
Recruitment Status : Completed
First Posted : January 7, 2013
Last Update Posted : January 7, 2013
SK Chemicals Co., Ltd.
Information provided by (Responsible Party):
Yonsei University